Oncology Drugs Market

研究執行與發布：Grand View Research　·　發布日期 2026-08-25　·　150 頁
由量子訊息有限公司（Quantum Information）在台灣代理銷售與提供授權諮詢。

完整報告名稱與涵蓋範圍

Oncology Drugs Market Size, Share & Trends Analysis Report By Drug Class (Chemotherapy, Targeted Therapy, Immunotherapy), By Cancer Type, By Route of Administration, By Drug Type, By Distribution Channel, By Region, And Segment Forecasts, 2026 - 2033

報告摘要

Oncology Drugs Market Summary The global oncology drugs market size was valued at USD 257.6 billion in 2025 and is projected to grow from USD 280.7 billion in 2026 to USD 541.6 billion by 2033, at a CAGR of 9.8% from 2026 to 2033. North America dominated the market, accounting for the largest revenue share of 41.2% in 2025. The market is expanding due to the rising global burden of cancer, increasing adoption of precision medicine, and continued investment in innovative therapies. Growing use of immunotherapies, targeted therapies, and cell-based treatments is improving clinical outcomes across multiple tumor types and supporting market growth. Advances in biomarker testing and genomic profiling are enabling more personalized treatment approaches, while faster regulatory pathways for therapies addressing unmet medical needs are accelerating product launches. Expanding healthcare expenditure and improving access to cancer diagnosis and treatment in emerging economies are further supporting demand. However, high treatment costs, reimbursement challenges, and pricing pressure from generic and biosimilar products continue to influence market performance. Complex clinical development processes and stringent regulatory requirements also affect the pace of commercialization. Despite these challenges, ongoing research collaborations, an increasing number of oncology clinical trials, and broader integration of companion diagnostics are expected to strengthen the development pipeline and create opportunities for sustained market expansion in both developed and emerging healthcare markets. Global Oncology Drugs Market Report Segmentation This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the global oncology drugs market report based on drug class, cancer type, route of administration, drug type, distribution channel, and region: • Drug Class Outlook (Revenue, USD Billion, 2021 - 2033) • Chemotherapy • Targeted Therapy • Immunotherapy • Hormonal Therapy • Radiopharmaceuticals • Cell & Gene Therapy • Others • Cancer Type Outlook (Revenue, USD Billion, 2021 - 2033) • Solid Tumors • Hematologic Malignancies • Route of Administration Outlook (Revenue, USD Billion, 2021 - 2033) • Oral • Injectable • Others • Drug Type Outlook (Revenue, USD Billion, 2021 - 2033) • Branded • Generic & Biosimilar • Distribution Channel Outlook (Revenue, USD Billion, 2021 - 2033) • Hospital Pharmacies • Retail Pharmacies • Online Pharmacies • Regional Outlook (Revenue, USD Billion, 2021 - 2033) • North America o U.S. o Canada o Mexico • Europe o UK o Germany o France o Italy o Spain o Denmark o Sweden o Norway • Asia Pacific o Japan o China o India o Australia o South Korea o Thailand • Latin America o Brazil o Argentina • Middle East & Africa o South Africa o Saudi Arabia o UAE o Kuwait

授權報價

Single User License	$5,950 USD
Enterprise License	$6,950 USD
Corporate User License	$8,950 USD

目錄 Table of Contents

Table of Contents Chapter 1. Methodology and Scope 1.1. Market Segmentation & Scope 1.2. Segment Definitions 1.2.1. Drug Class 1.2.2. Cancer Type 1.2.3. Route of Administration 1.2.4. Drug Type 1.2.5. Distribution Channel 1.3. Estimates and Forecast Timeline 1.4. Research Methodology 1.5. Information Procurement 1.5.1. Purchased Database 1.5.2. GVR’s Internal Database 1.5.3. Secondary Sources 1.5.4. Primary Research 1.6. Information Analysis 1.6.1. Data Analysis Models 1.7. Market Formulation & Data Visualization 1.8. Model Details 1.9. List of Secondary Sources 1.10. Objectives Chapter 2. Executive Summary 2.1. Market Snapshot 2.2. Segment Snapshot 2.3. Competitive Landscape Snapshot Chapter 3. Oncology Drugs Market Variables, Trends, & Scope 3.1. Market Lineage Outlook 3.2. Market Dynamics 3.2.1. Market Driver Analysis 3.2.2. Market Restraint Analysis 3.3. Business Environment Analysis 3.3.1. Industry Analysis - Porter’s Five Forces Analysis 3.3.1.1. Supplier Power 3.3.1.2. Buyer Power 3.3.1.3. Substitution Threat 3.3.1.4. Threat of New Entrants 3.3.1.5. Competitive Rivalry 3.3.2. PESTLE Analysis 3.3.3. Pipeline Analysis 3.3.4. Patent Expiry Analysis 3.3.5. Pricing Analysis Chapter 4. Oncology Drugs Market: Drug Class Business Analysis 4.1. Drug Class Market Share, 2025 & 2033 4.2. Drug Class Segment Dashboard 4.3. Market Size & Forecasts and Trend Analysis, by Drug Class, 2021 to 2033 (USD Billion) 4.4. Chemotherapy 4.4.1. Chemotherapy Market, 2021 - 2033 (USD Billion) 4.5. Targeted Therapy 4.5.1. Targeted Therapy Market, 2021 - 2033 (USD Billion) 4.6. Immunotherapy 4.6.1. Immunotherapy Market, 2021 - 2033 (USD Billion) 4.7. Hormonal Therapy 4.7.1. Hormonal Therapy Market, 2021 - 2033 (USD Billion) 4.8. Radiopharmaceuticals 4.8.1. Radiopharmaceuticals Market, 2021 - 2033 (USD Billion) 4.9. Cell & Gene Therapy 4.9.1. Cell & Gene Therapy Market, 2021 - 2033 (USD Billion) 4.10. Others 4.10.1. Others Market, 2021 - 2033 (USD Billion) Chapter 5. Oncology Drugs Market: Cancer Type Business Analysis 5.1. Cancer Type Market Share, 2025 & 2033 5.2. Cancer Type Segment Dashboard 5.3. Market Size & Forecasts and Trend Analysis, by Cancer Type, 2021 to 2033 (USD Billion) 5.4. Solid Tumors 5.4.1. Solid Tumors Market, 2021 - 2033 (USD Billion) 5.5. Hematologic Malignancies 5.5.1. Hematologic Malignancies Market, 2021 - 2033 (USD Billion) Chapter 6. Oncology Drugs Market: Route of Administration Business Analysis 6.1. Route of Administration Market Share, 2025 & 2033 6.2. Route of Administration Segment Dashboard 6.3. Market Size & Forecasts and Trend Analysis, by Route of Administration, 2021 to 2033 (USD Billion) 6.4. Oral 6.4.1. Oral Market, 2021 - 2033 (USD Billion) 6.5. Injectable 6.5.1. Injectable Market, 2021 - 2033 (USD Billion) 6.6. Others 6.6.1. Others Market, 2021 - 2033 (USD Billion) Chapter 7. Oncology Drugs Market: Drug Type Business Analysis 7.1. Drug Type Market Share, 2025 & 2033 7.2. Drug Type Segment Dashboard 7.3. Market Size & Forecasts and Trend Analysis, by Drug Type, 2021 to 2033 (USD Billion) 7.4. Branded 7.4.1. Branded Market, 2021 - 2033 (USD Billion) 7.5. Generic & Biosimilar 7.5.1. Generic & Biosimilar Market, 2021 - 2033 (USD Billion) Chapter 8. Oncology Drugs Market: Distribution Channel Business Analysis 8.1. Distribution Channel Market Share, 2025 & 2033 8.2. Distribution Channel Segment Dashboard 8.3. Market Size & Forecasts and Trend Analysis, by Distribution Channel, 2021 to 2033 (USD Billion) 8.4. Hospital Pharmacies 8.4.1. Hospital Pharmacies Market, 2021 - 2033 (USD Billion) 8.5. Retail Pharmacies 8.5.1. Retail Pharmacies Market, 2021 - 2033 (USD Billion) 8.6. Online Pharmacies 8.6.1. Online Pharmacies Market, 2021 - 2033 (USD Billion) Chapter 9. Oncology Drugs Market: Regional Estimates & Trend Analysis 9.1. Regional Market Share Analysis, 2025 & 2033 9.2. Regional Market Dashboard 9.3. Market Size & Forecasts Trend Analysis, 2021 to 2033: 9.4. North America 9.4.1. North America Oncology Drugs Market Estimates and Forecasts, By Country, 2021-2033 (USD Billion) 9.4.2. U.S. 9.4.2.1. Key Country Dynamics 9.4.2.2. Target Disease Prevalence 9.4.2.3. Regulatory Framework 9.4.2.4. Reimbursement Framework 9.4.2.5. U.S. Oncology Drugs Market Estimates and Forecasts, 2021-2033 (USD Billion) 9.4.3. Canada 9.4.3.1. Key Country Dynamics 9.4.3.2. Target Disease Prevalence 9.4.3.3. Regulatory Framework 9.4.3.4. Reimbursement Framework 9.4.3.5. Canada Oncology Drugs Market Estimates and Forecasts, 2021-2033 (USD Billion) 9.4.4. Mexico 9.4.4.1. Key Country Dynamics 9.4.4.2. Target Disease Prevalence 9.4.4.3. Regulatory Framework 9.4.4.4. Reimbursement Framework 9.4.4.5. Mexico Oncology Drugs Market Estimates and Forecasts, 2021-2033 (USD Billion) 9.5. Europe 9.5.1. Europe Oncology Drugs Market Estimates and Forecasts, 2021-2033 (USD Billion) 9.5.2. UK 9.5.2.1. Key Country Dynamics 9.5.2.2. Target Disease Prevalence 9.5.2.3. Regulatory Framework 9.5.2.4. Reimbursement Framework 9.5.2.5. UK Oncology Drugs Market Estimates and Forecasts, 2021-2033 (USD Billion) 9.5.3. Germany 9.5.3.1. Key Country Dynamics 9.5.3.2. Target Disease Prevalence 9.5.3.3. Regulatory Framework 9.5.3.4. Reimbursement Framework 9.5.3.5. Germany Oncology Drugs Market Estimates and Forecasts, 2021-2033 (USD Billion) 9.5.4. France 9.5.4.1. Key Country Dynamics 9.5.4.2. Target Disease Prevalence 9.5.4.3. Regulatory Framework 9.5.4.4. Reimbursement Framework 9.5.4.5. France Oncology Drugs Market Estimates and Forecasts, 2021-2033 (USD Billion) 9.5.5. Italy 9.5.5.1. Key Country Dynamics 9.5.5.2. Target Disease Prevalence 9.5.5.3. Regulatory Framework 9.5.5.4. Reimbursement Framework 9.5.5.5. Italy Oncology Drugs Market Estimates and Forecasts, 2021-2033 (USD Billion) 9.5.6. Spain 9.5.6.1. Key Country Dynamics 9.5.6.2. Target Disease Prevalence 9.5.6.3. Regulatory Framework 9.5.6.4. Reimbursement Framework 9.5.6.5. Spain Oncology Drugs Market Estimates and Forecasts, 2021-2033 (USD Billion) 9.5.7. Denmark 9.5.7.1. Key Country Dynamics 9.5.7.2. Target Disease Prevalence 9.5.7.3. Regulatory Framework 9.5.7.4. Reimbursement Framework 9.5.7.5. Denmark Oncology Drugs Market Estimates and Forecasts, 2021-2033 (USD Billion) 9.5.8. Sweden 9.5.8.1. Key Country Dynamics 9.5.8.2. Target Disease Prevalence 9.5.8.3. Regulatory Framework 9.5.8.4. Reimbursement Framework 9.5.8.5. Sweden Oncology Drugs Market Estimates and Forecasts, 2021-2033 (USD Billion) 9.5.9. Norway 9.5.9.1. Key Country Dynamics 9.5.9.2. Target Disease Prevalence 9.5.9.3. Regulatory Framework 9.5.9.4. Reimbursement Framework 9.5.9.5. Norway Oncology Drugs Market Estimates and Forecasts, 2021-2033 (USD Billion) 9.6. Asia Pacific 9.6.1. Asia Pacific Oncology Drugs Market Estimates and Forecasts, 2021-2033 (USD Billion) 9.6.2. Japan 9.6.2.1. Key Country Dynamics 9.6.2.2. Target Disease Prevalence 9.6.2.3. Regulatory Framework 9.6.2.4. Reimbursement Framework 9.6.2.5. Japan Oncology Drugs Market Estimates and Forecasts, 2021-2033 (USD Billion) 9.6.3. China 9.6.3.1. Key Country Dynamics 9.6.3.2. Target Disease Prevalence 9.6.3.3. Regulatory Framework 9.6.3.4. Reimbursement Framework 9.6.3.5. China Oncology Drugs Market Estimates and Forecasts, 2021-2033 (USD Billion) 9.6.4. India 9.6.4.1. Key Country Dynamics 9.6.4.2. Target Disease Prevalence 9.6.4.3. Regulatory Framework 9.6.4.4. Reimbursement Framework 9.6.4.5. India Oncology Drugs Market Estimates and Forecasts, 2021-2033 (USD Billion) 9.6.5. Australia 9.6.5.1. Key Country Dynamics 9.6.5.2. Target Disease Prevalence 9.6.5.3. Regulatory Framework 9.6.5.4. Reimbursement Framework 9.6.5.5. Australia Oncology Drugs Market Estimates and Forecasts, 2021-2033 (USD Billion) 9.6.6. South Korea 9.6.6.1. Key Country Dynamics 9.6.6.2. Target Disease Prevalence 9.6.6.3. Regulatory Framework 9.6.6.4. Reimbursement Framework 9.6.6.5. South Korea Oncology Drugs Market Estimates and Forecasts, 2021-2033 (USD Billion) 9.6.7. Thailand 9.6.7.1. Key Country Dynamics 9.6.7.2. Target Disease Prevalence 9.6.7.3. Regulatory Framework 9.6.7.4. Reimbursement Framework 9.6.7.5. Thailand Oncology Drugs Market Estimates and Forecasts, 2021-2033 (USD Billion) 9.7. Latin America 9.7.1. Latin America Oncology Drugs Market Estimates and Forecasts, 2021-2033 (USD Billion) 9.7.2. Brazil 9.7.2.1. Key Country Dynamics 9.7.2.2. Target Disease Prevalence 9.7.2.3. Regulatory Framework 9.7.2.4. Reimbursement Framework 9.7.2.5. Brazil Oncology Drugs Market Estimates and Forecasts, 2021-2033 (USD Billion) 9.7.3. Argentina 9.7.3.1. Key Country Dynamics 9.7.3.2. Target Disease Prevalence 9.7.3.3. Regulatory Framework 9.7.3.4. Reimbursement Framework 9.7.3.5. Argentina Oncology Drugs Market Estimates and Forecasts, 2021-2033 (USD Billion) 9.8. Middle East and Africa 9.8.1. Middle East and Africa Oncology Drugs Market Estimates and Forecasts, 2021 - 2033 (USD Billion) 9.8.2. South Africa 9.8.2.1. Key Country Dynamics 9.8.2.2. Target Disease Prevalence 9.8.2.3. Regulatory Framework 9.8.2.4. Reimbursement Framework 9.8.2.5. South Africa Oncology Drugs Market Estimates and Forecasts, 2021-2033 (USD Billion) 9.8.3. Saudi Arabia 9.8.3.1. Key Country Dynamics 9.8.3.2. Target Disease Prevalence 9.8.3.3. Regulatory Framework 9.8.3.4. Reimbursement Framework 9.8.3.5. Saudi Arabia Oncology Drugs Market Estimates and Forecasts, 2021-2033 (USD Billion) 9.8.4. UAE 9.8.4.1. Key Country Dynamics 9.8.4.2. Target Disease Prevalence 9.8.4.3. Regulatory Framework 9.8.4.4. Reimbursement Framework 9.8.4.5. UAE Oncology Drugs Market Estimates and Forecasts, 2021-2033 (USD Billion) 9.8.5. Kuwait 9.8.5.1. Key Country Dynamics 9.8.5.2. Target Disease Prevalence 9.8.5.3. Regulatory Framework 9.8.5.4. Reimbursement Framework 9.8.5.5. Kuwait Oncology Drugs Market Estimates and Forecasts, 2021-2033 (USD Billion) Chapter 10. Competitive Landscape 10.1. Participant Overview 10.2. Company Market Position Analysis 10.3. Company Categorization 10.4. Strategy Mapping 10.5. Company Profiles/Listing 10.5.1. Roche Holding AG 10.5.1.1. Overview 10.5.1.2. Financial Performance 10.5.1.3. Product Benchmarking 10.5.1.4. Strategic Initiatives 10.5.2. Merck & Co., Inc. 10.5.2.1. Overview 10.5.2.2. Financial Performance 10.5.2.3. Product Benchmarking 10.5.2.4. Strategic Initiatives 10.5.3. AstraZeneca PLC 10.5.3.1. Overview 10.5.3.2. Financial Performance 10.5.3.3. Product Benchmarking 10.5.3.4. Strategic Initiatives 10.5.4. Bristol Myers Squibb 10.5.4.1. Overview 10.5.4.2. Financial Performance 10.5.4.3. Product Benchmarking 10.5.4.4. Strategic Initiatives 10.5.5. Pfizer Inc. 10.5.5.1. Overview 10.5.5.2. Financial Performance 10.5.5.3. Product Benchmarking 10.5.5.4. Strategic Initiatives 10.5.6. Novartis AG 10.5.6.1. Overview 10.5.6.2. Financial Performance 10.5.6.3. Product Benchmarking 10.5.6.4. Strategic Initiatives 10.5.7. Johnson & Johnson 10.5.7.1. Overview 10.5.7.2. Financial Performance 10.5.7.3. Product Benchmarking 10.5.7.4. Strategic Initiatives 10.5.8. Eli Lilly and Company 10.5.8.1. Overview 10.5.8.2. Financial Performance 10.5.8.3. Product Benchmarking 10.5.8.4. Strategic Initiatives 10.5.9. GSK plc 10.5.9.1. Overview 10.5.9.2. Financial Performance 10.5.9.3. Product Benchmarking 10.5.9.4. Strategic Initiatives 10.5.10. Amgen Inc. 10.5.10.1. Overview 10.5.10.2. Financial Performance 10.5.10.3. Product Benchmarking 10.5.10.4. Strategic Initiatives

圖表清單 List of Tables & Figures

List of Tables Table 1 List of Secondary Sources Table 2 List of Abbreviations Table 3 Global Oncology Drugs Market, By Region, 2021 - 2033 (USD Billion) Table 4 Global Oncology Drugs Market, By Drug Class, 2021 - 2033 (USD Billion) Table 5 Global Oncology Drugs Market, By Cancer Type, 2021 - 2033 (USD Billion) Table 6 Global Oncology Drugs Market, By Route of Administration, 2021 - 2033 (USD Billion) Table 7 Global Oncology Drugs Market, By Drug Type, 2021 - 2033 (USD Billion) Table 8 Global Oncology Drugs Market, By Distribution Channel, 2021 - 2033 (USD Billion) Table 9 North America Oncology Drugs Market, By Country, 2021 - 2033 (USD Billion) Table 10 North America Oncology Drugs Market, By Drug Class, 2021 - 2033 (USD Billion) Table 11 North America Oncology Drugs Market, By Cancer Type, 2021 - 2033 (USD Billion) Table 12 North America Oncology Drugs Market, By Route of Administration, 2021 - 2033 (USD Billion) Table 13 North America Oncology Drugs Market, By Drug Type, 2021 - 2033 (USD Billion) Table 14 North America Oncology Drugs Market, By Distribution Channel, 2021 - 2033 (USD Billion) Table 15 U.S. Oncology Drugs Market, By Drug Class, 2021 - 2033 (USD Billion) Table 16 U.S. Oncology Drugs Market, By Cancer Type, 2021 - 2033 (USD Billion) Table 17 U.S. Oncology Drugs Market, By Route of Administration, 2021 - 2033 (USD Billion) Table 18 U.S Oncology Drugs Market, By Drug Type, 2021 - 2033 (USD Billion) Table 19 U.S Oncology Drugs Market, By Distribution Channel, 2021 - 2033 (USD Billion) Table 20 Canada Oncology Drugs Market, By Drug Class, 2021 - 2033 (USD Billion) Table 21 Canada Oncology Drugs Market, By Cancer Type, 2021 - 2033 (USD Billion) Table 22 Canada Oncology Drugs Market, By Route of Administration, 2021 - 2033 (USD Billion) Table 23 Canada Oncology Drugs Market, By Drug Type, 2021 - 2033 (USD Billion) Table 24 Canada Oncology Drugs Market, By Distribution Channel, 2021 - 2033 (USD Billion) Table 25 Mexico Oncology Drugs Market, By Drug Class, 2021 - 2033 (USD Billion) Table 26 Mexico Oncology Drugs Market, By Cancer Type, 2021 - 2033 (USD Billion) Table 27 Mexico Oncology Drugs Market, By Route of Administration, 2021 - 2033 (USD Billion) Table 28 Mexico Oncology Drugs Market, By Drug Type, 2021 - 2033 (USD Billion) Table 29 Mexico Oncology Drugs Market, By Distribution Channel, 2021 - 2033 (USD Billion) Table 30 Europe Oncology Drugs Market, By Country, 2021 - 2033 (USD Billion) Table 31 Europe Oncology Drugs Market, By Drug Class, 2021 - 2033 (USD Billion) Table 32 Europe Oncology Drugs Market, By Cancer Type, 2021 - 2033 (USD Billion) Table 33 Europe Oncology Drugs Market, By Route of Administration, 2021 - 2033 (USD Billion) Table 34 Europe Oncology Drugs Market, By Drug Type, 2021 - 2033 (USD Billion) Table 35 Europe Oncology Drugs Market, By Distribution Channel, 2021 - 2033 (USD Billion) Table 36 UK Oncology Drugs Market, By Drug Class, 2021 - 2033 (USD Billion) Table 37 UK Oncology Drugs Market, By Cancer Type, 2021 - 2033 (USD Billion) Table 38 UK Oncology Drugs Market, By Route of Administration, 2021 - 2033 (USD Billion) Table 39 UK Oncology Drugs Market, By Drug Type, 2021 - 2033 (USD Billion) Table 40 UK Oncology Drugs Market, By Distribution Channel, 2021 - 2033 (USD Billion) Table 41 Germany Oncology Drugs Market, By Drug Class, 2021 - 2033 (USD Billion) Table 42 Germany Oncology Drugs Market, By Cancer Type, 2021 - 2033 (USD Billion) Table 43 Germany Oncology Drugs Market, By Route of Administration, 2021 - 2033 (USD Billion) Table 44 Germany Oncology Drugs Market, By Drug Type, 2021 - 2033 (USD Billion) Table 45 Germany Oncology Drugs Market, By Distribution Channel, 2021 - 2033 (USD Billion) Table 46 France Oncology Drugs Market, By Drug Class, 2021 - 2033 (USD Billion) Table 47 France Oncology Drugs Market, By Cancer Type, 2021 - 2033 (USD Billion) Table 48 France Oncology Drugs Market, By Route of Administration, 2021 - 2033 (USD Billion) Table 49 France Oncology Drugs Market, By Drug Type, 2021 - 2033 (USD Billion) Table 50 France Oncology Drugs Market, By Distribution Channel, 2021 - 2033 (USD Billion) Table 51 Italy Oncology Drugs Market, By Drug Class, 2021 - 2033 (USD Billion) Table 52 Italy Oncology Drugs Market, By Cancer Type, 2021 - 2033 (USD Billion) Table 53 Italy Oncology Drugs Market, By Route of Administration, 2021 - 2033 (USD Billion) Table 54 Italy Oncology Drugs Market, By Drug Type, 2021 - 2033 (USD Billion) Table 55 Italy Oncology Drugs Market, By Distribution Channel, 2021 - 2033 (USD Billion) Table 56 Spain Oncology Drugs Market, By Drug Class, 2021 - 2033 (USD Billion) Table 57 Spain Oncology Drugs Market, By Cancer Type, 2021 - 2033 (USD Billion) Table 58 Spain Oncology Drugs Market, By Route of Administration, 2021 - 2033 (USD Billion) Table 59 Spain Oncology Drugs Market, By Drug Type, 2021 - 2033 (USD Billion) Table 60 Spain Oncology Drugs Market, By Distribution Channel, 2021 - 2033 (USD Billion) Table 61 Norway Oncology Drugs Market, By Drug Class, 2021 - 2033 (USD Billion) Table 62 Norway Oncology Drugs Market, By Cancer Type, 2021 - 2033 (USD Billion) Table 63 Norway Oncology Drugs Market, By Route of Administration, 2021 - 2033 (USD Billion) Table 64 Norway Oncology Drugs Market, By Drug Type, 2021 - 2033 (USD Billion) Table 65 Norway Oncology Drugs Market, By Distribution Channel, 2021 - 2033 (USD Billion) Table 66 Denmark Oncology Drugs Market, By Drug Class, 2021 - 2033 (USD Billion) Table 67 Denmark Oncology Drugs Market, By Cancer Type, 2021 - 2033 (USD Billion) Table 68 Denmark Oncology Drugs Market, By Route of Administration, 2021 - 2033 (USD Billion) Table 69 Denmark Oncology Drugs Market, By Drug Type, 2021 - 2033 (USD Billion) Table 70 Denmark Oncology Drugs Market, By Distribution Channel, 2021 - 2033 (USD Billion) Table 71 Sweden Oncology Drugs Market, By Drug Class, 2021 - 2033 (USD Billion) Table 72 Sweden Oncology Drugs Market, By Cancer Type, 2021 - 2033 (USD Billion) Table 73 Sweden Oncology Drugs Market, By Route of Administration, 2021 - 2033 (USD Billion) Table 74 Sweden Oncology Drugs Market, By Drug Type, 2021 - 2033 (USD Billion) Table 75 Sweden Oncology Drugs Market, By Distribution Channel, 2021 - 2033 (USD Billion) Table 76 Asia Pacific Oncology Drugs Market, By Country, 2021 - 2033 (USD Billion) Table 77 Asia Pacific Oncology Drugs Market, By Drug Class, 2021 - 2033 (USD Billion) Table 78 Asia Pacific Oncology Drugs Market, By Cancer Type, 2021 - 2033 (USD Billion) Table 79 Asia Pacific Oncology Drugs Market, By Route of Administration, 2021 - 2033 (USD Billion) Table 80 Asia Pacific Oncology Drugs Market, By Drug Type, 2021 - 2033 (USD Billion) Table 81 Asia Pacific Oncology Drugs Market, By Distribution Channel, 2021 - 2033 (USD Billion) Table 82 Japan Oncology Drugs Market, By Drug Class, 2021 - 2033 (USD Billion) Table 83 Japan Oncology Drugs Market, By Cancer Type, 2021 - 2033 (USD Billion) Table 84 Japan Oncology Drugs Market, By Route of Administration, 2021 - 2033 (USD Billion) Table 85 Japan Oncology Drugs Market, By Drug Type, 2021 - 2033 (USD Billion) Table 86 Japan Oncology Drugs Market, By Distribution Channel, 2021 - 2033 (USD Billion) Table 87 China Oncology Drugs Market, By Drug Class, 2021 - 2033 (USD Billion) Table 88 China Oncology Drugs Market, By Cancer Type, 2021 - 2033 (USD Billion) Table 89 China Oncology Drugs Market, By Route of Administration, 2021 - 2033 (USD Billion) Table 90 China Oncology Drugs Market, By Drug Type, 2021 - 2033 (USD Billion) Table 91 China Oncology Drugs Market, By Distribution Channel, 2021 - 2033 (USD Billion) Table 92 India Oncology Drugs Market, By Drug Class, 2021 - 2033 (USD Billion) Table 93 India Oncology Drugs Market, By Cancer Type, 2021 - 2033 (USD Billion) Table 94 India Oncology Drugs Market, By Route of Administration, 2021 - 2033 (USD Billion) Table 95 India Oncology Drugs Market, By Drug Type, 2021 - 2033 (USD Billion) Table 96 India Oncology Drugs Market, By Distribution Channel, 2021 - 2033 (USD Billion) Table 97 Australia Oncology Drugs Market, By Drug Class, 2021 - 2033 (USD Billion) Table 98 Australia Oncology Drugs Market, By Cancer Type, 2021 - 2033 (USD Billion) Table 99 Australia Oncology Drugs Market, By Route of Administration, 2021 - 2033 (USD Billion) Table 100 Australia Oncology Drugs Market, By Drug Type, 2021 - 2033 (USD Billion) Table 101 Australia Oncology Drugs Market, By Distribution Channel, 2021 - 2033 (USD Billion) Table 102 South Korea Oncology Drugs Market, By Drug Class, 2021 - 2033 (USD Billion) Table 103 South Korea Oncology Drugs Market, By Cancer Type, 2021 - 2033 (USD Billion) Table 104 South Korea Oncology Drugs Market, By Route of Administration, 2021 - 2033 (USD Billion) Table 105 South Korea Oncology Drugs Market, By Drug Type, 2021 - 2033 (USD Billion) Table 106 South Korea Oncology Drugs Market, By Distribution Channel, 2021 - 2033 (USD Billion) Table 107 Thailand Oncology Drugs Market, By Drug Class, 2021 - 2033 (USD Billion) Table 108 Thailand Oncology Drugs Market, By Cancer Type, 2021 - 2033 (USD Billion) Table 109 Thailand Oncology Drugs Market, By Route of Administration, 2021 - 2033 (USD Billion) Table 110 Thailand Oncology Drugs Market, By Drug Type, 2021 - 2033 (USD Billion) Table 111 Thailand Oncology Drugs Market, By Distribution Channel, 2021 - 2033 (USD Billion) Table 112 Latin America Oncology Drugs Market, By Country, 2021 - 2033 (USD Billion) Table 113 Latin America Oncology Drugs Market, By Drug Class, 2021 - 2033 (USD Billion) Table 114 Latin America Oncology Drugs Market, By Cancer Type, 2021 - 2033 (USD Billion) Table 115 Latin America Oncology Drugs Market, By Route of Administration, 2021 - 2033 (USD Billion) Table 116 Latin America Oncology Drugs Market, By Drug Type, 2021 - 2033 (USD Billion) Table 117 Latin America Oncology Drugs Market, By Distribution Channel, 2021 - 2033 (USD Billion) Table 118 Brazil Oncology Drugs Market, By Drug Class, 2021 - 2033 (USD Billion) Table 119 Brazil Oncology Drugs Market, By Cancer Type, 2021 - 2033 (USD Billion) Table 120 Brazil Oncology Drugs Market, By Route of Administration, 2021 - 2033 (USD Billion) Table 121 Brazil Oncology Drugs Market, By Drug Type, 2021 - 2033 (USD Billion) Table 122 Brazil Oncology Drugs Market, By Distribution Channel, 2021 - 2033 (USD Billion) Table 123 Argentina Oncology Drugs Market, By Drug Class, 2021 - 2033 (USD Billion) Table 124 Argentina Oncology Drugs Market, By Cancer Type, 2021 - 2033 (USD Billion) Table 125 Argentina Oncology Drugs Market, By Route of Administration, 2021 - 2033 (USD Billion) Table 126 Argentina Oncology Drugs Market, By Drug Type, 2021 - 2033 (USD Billion) Table 127 Argentina Oncology Drugs Market, By Distribution Channel, 2021 - 2033 (USD Billion) Table 128 Middle East & Africa Oncology Drugs Market, By Country, 2021 - 2033 (USD Billion) Table 129 Middle East & Africa Oncology Drugs Market, By Drug Class, 2021 - 2033 (USD Billion) Table 130 Middle East & Africa Oncology Drugs Market, By Cancer Type, 2021 - 2033 (USD Billion) Table 131 Middle East & Africa Oncology Drugs Market, By Route of Administration, 2021 - 2033 (USD Billion) Table 132 Middle East & Africa Oncology Drugs Market, By Drug Type, 2021 - 2033 (USD Billion) Table 133 Middle East & Africa Oncology Drugs Market, By Distribution Channel, 2021 - 2033 (USD Billion) Table 134 South Africa Oncology Drugs Market, By Drug Class, 2021 - 2033 (USD Billion) Table 135 South Africa Oncology Drugs Market, By Cancer Type, 2021 - 2033 (USD Billion) Table 136 South Africa Oncology Drugs Market, By Route of Administration, 2021 - 2033 (USD Billion) Table 137 South Africa Oncology Drugs Market, By Drug Type, 2021 - 2033 (USD Billion) Table 138 South Africa Oncology Drugs Market, By Distribution Channel, 2021 - 2033 (USD Billion) Table 139 Saudi Arabia Oncology Drugs Market, By Drug Class, 2021 - 2033 (USD Billion) Table 140 Saudi Arabia Oncology Drugs Market, By Cancer Type, 2021 - 2033 (USD Billion) Table 141 Saudi Arabia Oncology Drugs Market, By Route of Administration, 2021 - 2033 (USD Billion) Table 142 Saudi Arabia Oncology Drugs Market, By Drug Type, 2021 - 2033 (USD Billion) Table 143 Saudi Arabia Oncology Drugs Market, By Distribution Channel, 2021 - 2033 (USD Billion) Table 144 UAE Oncology Drugs Market, By Drug Class, 2021 - 2033 (USD Billion) Table 145 UAE Oncology Drugs Market, By Cancer Type, 2021 - 2033 (USD Billion) Table 146 UAE Oncology Drugs Market, By Route of Administration, 2021 - 2033 (USD Billion) Table 147 UAE Oncology Drugs Market, By Drug Type, 2021 - 2033 (USD Billion) Table 148 UAE Oncology Drugs Market, By Distribution Channel, 2021 - 2033 (USD Billion) Table 149 Kuwait Oncology Drugs Market, By Drug Class, 2021 - 2033 (USD Billion) Table 150 Kuwait Oncology Drugs Market, By Cancer Type, 2021 - 2033 (USD Billion) Table 151 Kuwait Oncology Drugs Market, By Route of Administration, 2021 - 2033 (USD Billion) Table 152 Kuwait Oncology Drugs Market, By Drug Type, 2021 - 2033 (USD Billion) Table 153 Kuwait Oncology Drugs Market, By Distribution Channel, 2021 - 2033 (USD Billion) List of Figures Fig. 1 Oncology Drugs Market Segmentation Fig. 2 Market Research Process Fig. 3 Data Triangulation Techniques Fig. 4 Primary Research Pattern Fig. 5 Market Research Approaches Fig. 6 Value-Chain-Based Sizing & Forecasting Fig. 7 Market Formulation & Validation Fig. 8 Market Snapshot Fig. 9 Competitive Landscape Fig. 10 Oncology Drugs Market Dynamics Fig. 11 Oncology Drugs Market: Porter’s Five Forces Analysis Fig. 12 Oncology Drugs Market: PESTLE Analysis Fig. 13 Drug Class Market, 2021 - 2033 (USD Billion) Fig. 14 Chemotherapy Market, 2021 - 2033 (USD Billion) Fig. 15 Targeted Therapy Market, 2021 - 2033 (USD Billion) Fig. 16 Immunotherapy Market, 2021 - 2033 (USD Billion) Fig. 17 Hormonal Therapy Market, 2021 - 2033 (USD Billion) Fig. 18 Radiopharmaceuticals Market, 2021 - 2033 (USD Billion) Fig. 19 Cell & Gene Therapy Market, 2021 - 2033 (USD Billion) Fig. 20 Others Market, 2021 - 2033 (USD Billion) Fig. 21 Cancer Type Market, 2021 - 2033 (USD Billion) Fig. 22 Solid Tumors Market, 2021 - 2033 (USD Billion) Fig. 23 Hematologic Malignancies Market, 2021 - 2033 (USD Billion) Fig. 24 Route of Administration Market, 2021 - 2033 (USD Billion) Fig. 25 Oral Market, 2021 - 2033 (USD Billion) Fig. 26 Injectable Market, 2021 - 2033 (USD Billion) Fig. 27 Others Market, 2021 - 2033 (USD Billion) Fig. 28 Drug Type Market, 2021 - 2033 (USD Billion) Fig. 29 Branded Market, 2021 - 2033 (USD Billion) Fig. 30 Generic & Biosimilar Market, 2021 - 2033 (USD Billion) Fig. 31 Distribution Channel Market, 2021 - 2033 (USD Billion) Fig. 32 Hospital Pharmacies Market, 2021 - 2033 (USD Billion) Fig. 33 Retail Pharmacies Market, 2021 - 2033 (USD Billion) Fig. 34 Online Pharmacies Market, 2021 - 2033 (USD Billion) Fig. 35 Oncology Drugs Market Revenue, By Region Fig. 36 Regional Marketplace: Key Takeaways Fig. 37 North America Oncology Drugs Market, 2021 - 2033 (USD Billion) Fig. 38 U.S. Country Dynamics Fig. 39 U.S. Oncology Drugs Market, 2021 - 2033 (USD Billion) Fig. 40 Canada Country Dynamics Fig. 41 Canada Oncology Drugs Market, 2021 - 2033 (USD Billion) Fig. 42 Mexico Country Dynamics Fig. 43 Mexico Oncology Drugs Market, 2021 - 2033 (USD Billion) Fig. 44 Europe Oncology Drugs Market, 2021 - 2033 (USD Billion) Fig. 45 UK Country Dynamics Fig. 46 UK Oncology Drugs Market, 2021 - 2033 (USD Billion) Fig. 47 Germany Country Dynamics Fig. 48 Germany Oncology Drugs Market, 2021 - 2033 (USD Billion) Fig. 49 France Country Dynamics Fig. 50 France Oncology Drugs Market, 2021 - 2033 (USD Billion) Fig. 51 Italy Country Dynamics Fig. 52 Italy Oncology Drugs Market, 2021 - 2033 (USD Billion) Fig. 53 Spain Country Dynamics Fig. 54 Spain Oncology Drugs Market, 2021 - 2033 (USD Billion) Fig. 55 Norway Country Dynamics Fig. 56 Norway Oncology Drugs Market, 2021 - 2033 (USD Billion) Fig. 57 Sweden Country Dynamics Fig. 58 Sweden Oncology Drugs Market, 2021 - 2033 (USD Billion) Fig. 59 Denmark Country Dynamics Fig. 60 Denmark Oncology Drugs Market, 2021 - 2033 (USD Billion) Fig. 61 Asia Pacific Oncology Drugs Market, 2021 - 2033 (USD Billion) Fig. 62 Japan Country Dynamics Fig. 63 Japan Oncology Drugs Market, 2021 - 2033 (USD Billion) Fig. 64 China Country Dynamics Fig. 65 China Oncology Drugs Market, 2021 - 2033 (USD Billion) Fig. 66 India Country Dynamics Fig. 67 India Oncology Drugs Market, 2021 - 2033 (USD Billion) Fig. 68 Australia Country Dynamics Fig. 69 Australia Oncology Drugs Market, 2021 - 2033 (USD Billion) Fig. 70 South Korea Country Dynamics Fig. 71 South Korea Oncology Drugs Market, 2021 - 2033 (USD Billion) Fig. 72 Thailand Country Dynamics Fig. 73 Thailand Oncology Drugs Market, 2021 - 2033 (USD Billion) Fig. 74 Latin America Oncology Drugs Market, 2021 - 2033 (USD Billion) Fig. 75 Brazil Country Dynamics Fig. 76 Brazil Oncology Drugs Market, 2021 - 2033 (USD Billion) Fig. 77 Argentina Country Dynamics Fig. 78 Argentina Oncology Drugs Market, 2021 - 2033 (USD Billion) Fig. 79 Middle East & Africa Oncology Drugs Market, 2021 - 2033 (USD Billion) Fig. 80 South Africa Country Dynamics Fig. 81 South Africa Oncology Drugs Market, 2021 - 2033 (USD Billion) Fig. 82 Saudi Arabia Country Dynamics Fig. 83 Saudi Arabia Oncology Drugs Market, 2021 - 2033 (USD Billion) Fig. 84 UAE Country Dynamics Fig. 85 UAE Oncology Drugs Market, 2021 - 2033 (USD Billion) Fig. 86 Kuwait Country Dynamics Fig. 87 Kuwait Oncology Drugs Market, 2021 - 2033 (USD Billion) Fig. 88 Company Categorization Fig. 89 Company Market Position Analysis Fig. 90 Strategic Framework

提及公司

Roche Holding AGMerck & Co., Inc.AstraZeneca PLCBristol Myers SquibbPfizer Inc.Novartis AGJohnson & JohnsonEli Lilly and CompanyGSK plcAmgen Inc.

常見問題

這份報告可以先索取樣本嗎？

可以。建議購買前先申請樣本，提出申請後約 2 個工作天內提供，您可以先確認內容涵蓋範圍是否符合需求。

報告價格如何計算？

報告以美元標價，台幣報價依當日匯率換算並加計 5% 營業稅。不同授權版本（單人／多人／企業全站）價格不同，量子訊息會評估您的使用情境後提供最優惠報價。

下單後多久交付？如何付款？

一般 3–7 個工作天交付，實際依出版商狀況於下單前確認。收到報告確認無誤後開立台幣發票，30 天內電匯付款即可。

量子訊息有限公司為 Grand View Research 在台灣的授權代理，提供報告購買、樣本申請與授權諮詢。電話 +886 2 7751 5192 ・聯絡我們